|Values are valid only on day of printing.|
Identifying individuals who are at increased risk of adverse drug reactions with irinotecan and who should be considered for decreased dosing of the drug.
Genotyping patients who prefer not to have venipuncture done
|Test ID||Reporting Name||Available Separately||Always Performed|
|UGT1O||UGT1A1 Gene Sequence, Irinotecan||No||Yes|
|UGTSQ||UGT, Full Gene Sequencing||No||Yes|
See UGT1A1 Test-Performing Algorithm in Special Instructions.
Polymerase Chain Reaction (PCR) Followed by Gene Sequencing
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)